Intesa Sanpaolo (I06728) 銘柄情報

Why Invest in RadioGel? The Future of Cancer Treatment

RadioGel® is poised to redefine radiation therapy, offering a groundbreaking solution for treating solid tumors with unparalleled precision and safety. Unlike conventional radiation therapy, which exposes healthy tissue to harmful

At least at the moment he cannot brag about how great the market is doing. Of course, many others not just elites live off the markets exclusively.😇

I once thought about 10 times that 375 was the new 273 and 371.

Excellent due diligence TenKay, as per usual.

Another week gone by....closer to the prize...Go BC management team and products!...I beliiieeeve!....GLTUA 🫡

Looks like the Tariff realization is sinking in as the markets have been selling off the last few weeks. Bargains for us just banking divies

...no worries.....re: NAOMI......WE - WE are sitting on both sides of the table.............and trust me, BAC and UBS and their battery of LAW FIRMS and $1.1-TRILLION in cash......are staring down at NAOMI................yes, she is in between the proverbial ROCK AND HARD PLACE.............this is b

He, wait... you are that UNCOVERED ERHE ALTRUIST with 8000 posts in his name, right?

You refered to ERHC as a 'Skull and Bones' disaster that you wanted to stay away from as far as possible, right? "as you are unable to discuss anything about erhc."
UNCOVERED CON-MAN, again..

INVZ...74...🥳...Some 70s buy orders filled this past week...

INVZ...74...🥳...Some 70s buy orders filled this past week...

I know he was just trying to please the tyrant, but he was not much better, imo.

INVZ...74...🥳...Some 70s buy orders filled this past week...

INVZ...74...🥳...Some 70s buy orders filled this past week...

Could it be that Dr. Lebby knows something big is about to happen and wants to be able to sell at a better pps? Not sure in this case but I believe the company has to approve or help in/with the filing/transfer agent and UBS Financial (Lebby's broker). He had opportunity since he left to have file

NEW ALL TIME LOWS !

Congratulations Longs !

Low share price makes it a desirable takeover target..

Since I follow and post my technical indicators frequently, I need to state although the month of March is strong in 3 out of four years this year, the post election year it is not usually. Thus, this is one factor that will lower my trading ambitions for the month, unless it will be proven otherwis

They have themes.
Mikah tax
2027
$2
NasRat
No vyvanse launch
Debt
No Nasdaq no pps up
Etc…

Patience is the key here. Why sell for pennies, that’s minuscule earnings when you can hold and sell for dollars. And that basher tencent is nothing but doom and gloom around these parts. Don’t listen to that spew of nonsense!

The revenues for 2025 are expected to be the highest in the public company history.
Digital Clarity confidently has forecast over $1 million in revenue for this fiscal year ending August 31, 2025.
The Company is reinforcing its expectation that 2025 will be the best year ever.

You might want to change your board name to Maxthedouche.

Insider Brief

IonQ, Inc. has appointed Niccolo de Masi as its new President and CEO, with Peter Chapman transitioning to the role of Executive Chair.
De Masi, a physicist by training, has extensive leadership experience in public companies and played a key role in taking IonQ p

The CDC and the FDA both announced the cancellations of their scheduled Advisory Committee meetings, which were intended to provide guidance which identified the viral strains to be targeted by pharmaceutical manufacturers. Both agencies fall under the purview of Bobby Kennedy's HHS Department. Cou